ID   SXMUi002-A
AC   CVCL_C0F5
SY   F8-hiPSC; HIPS-F8; SXMUi001-A-1
DR   BioSamples; SAMEA11645415
DR   hPSCreg; SXMUi002-A
DR   Wikidata; Q112930450
RX   Patent=CN114350614A;
RX   PubMed=35123343;
CC   Group: Patented cell line.
CC   From: Shanxi Medical University; Taiyuan; China.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.23095.
CC   Sequence variation: Mutation; HGNC; 3546; F8; Simple; p.Arg814Ter (c.2440C>T); ClinVar=VCV000993607; Zygosity=Hemizygous (PubMed=35123343).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): Patent=CN114350614A; PubMed=35123343
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 9,10
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D1S1656: 13,17
ST   D21S11: 31,33.2
ST   D2S1338: 19,21
ST   D3S1358: 14,17
ST   D5S818: 7,11
ST   D6S1043: 18,19
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 19,22
ST   Penta D: 9
ST   Penta E: 20
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
RX   Patent=CN114350614A;
RA   Wang G., Yang L.-H., Sun W.-W., Yao M.-Z., Wu C.-X., Liu X., Ren J.,
RA   Zhang R.-J., Zhang X.-L., Ma Y.-Y., Zhao L.-D.;
RT   "Human induced pluripotent stem cell and preparation method and
RT   application thereof.";
RL   Patent number CN114350614A, 15-Apr-2022.
//
RX   PubMed=35123343; DOI=10.1016/j.scr.2022.102682;
RA   Sun W.-W., Hu X.-C., Wang L.-Y., Ma Y.-C., Zhang X.-L., Zhang R.-J.,
RA   Zhao L.-D., Ren J., Yang L.-H., Wang G.;
RT   "Generation of iPSC line from urine cells of hemophilia A with F8 (p.
RT   R814X) mutation.";
RL   Stem Cell Res. 60:102682-102682(2022).
//